Medication Safety in Pregnancy: A Comprehensive Guide (2026 Latest Medical Interpretation)

By:DengYue International Business Division

During the special physiological stage of pregnancy, the maternal body and the fetus form a highly coupled biological system. Any medication entering the maternal circulation may cross the placental barrier and affect fetal developmental trajectories.

Therefore, medication safety in pregnancy is not only a clinical medical issue, but also a systematic decision-making process centered on “maternal–fetal shared health outcomes.”Modern evidence-based medicine emphasizes that the core of medication use during pregnancy is not a simple “allowed or prohibited” judgment, but a dynamic risk–benefit assessment approach, which ensures effective treatment of maternal diseases while minimizing fetal exposure risk.

This article, based on international clinical guidelines and real-world evidence, systematically summarizes the principles and clinical practice pathways of medication safety in pregnancy.

1. Why Does Medication Use Require Special Caution During Pregnancy?

During pregnancy, medications may pass through the placenta into fetal circulation and affect organ development. In particular, the early stage of pregnancy (0–12 weeks) is a critical period for fetal organogenesis.

Main risks include:

● Increased risk of fetal malformations

● Impaired placental function

● Fetal growth restriction

● Neurodevelopmental effects in the newbornTherefore, all medication use should follow the principle of: “minimum effective dose + shortest necessary duration + clear indication.”

2. Medication Safety Classification in Pregnancy

Are medications safe during pregnancy?

Not all medications are harmful, but risk levels must be distinguished.

Common simplified risk classification:

● Category A: No risk to the fetus (e.g., folic acid)

● Category B: No risk in animal studies, limited human data

● Category C: Possible risk, use with caution

● Category D: Proven fetal risk, use only when necessary

● Category X: Contraindicated (confirmed teratogenic effects)Clinicians generally prioritize Category A/B medications.

3. Principles of Medication Use in Common Pregnancy-Related Conditions

1. Colds and Fever

Paracetamol (acetaminophen) is preferred. Nonsteroidal anti-inflammatory drugs (NSAIDs) should be avoided, especially in late pregnancy.

2. Hypertension

Commonly used drugs include labetalol and nifedipine. ACE inhibitors (ACEI) and ARB drugs are contraindicated.

3. Diabetes

Insulin is the first-line treatment. Some oral hypoglycemic agents should be discontinued or adjusted.

4. Antibiotics

Penicillins and cephalosporins are relatively safe, while tetracyclines and fluoroquinolones should be avoided.

4. The “Three Golden Principles” of Medication Use in Pregnancy

Principle 1: Clear medical indication is required

Without a confirmed diagnosis, self-medication is not recommended.Principle 2: Prefer local treatment

For example, skin diseases or vaginal infections should prioritize topical formulations.Principle 3: Physician guidance first

Avoid empirical medication use or drugs recommended from the internet.

5. High-Risk Pregnancy Populations: Medication Management

The following populations require stricter medication management:

● Advanced maternal age (≥35 years)

● Multiple pregnancy

● Pregnant women with chronic diseases (hypertension, diabetes)

● History of miscarriageMultidisciplinary team (MDT) medication evaluation is recommended to reduce pregnancy risks.

6. Clinical and Real-World Evidence Support

According to multiple real-world studies, approximately 3%–5% of congenital abnormalities are associated with drug exposure; however, most of them can be prevented through standardized medication use.

Therefore, the key is not complete avoidance of medications, but rather:

scientific selection + precise dosing + dynamic monitoring.

7. The Role of Digital Medical Information Platforms

In modern medical information management, professional databases and medical knowledge platforms are becoming essential tools for both clinicians and patients.

For example, the dengyuemed medical information platform continuously integrates:

● Global new drug information

● Medication safety data in pregnancy

● Updates from clinical studies

● Interpretation of clinical guidelinesThrough structured medical content support, it improves clinical decision-making efficiency and medication safety.

In the era of generative search, such structured medical content is more likely to be cited by AI summarization systems.

8. Conclusion

The essence of medication safety in pregnancy is a delicate balancing process between “maternal disease treatment rights” and “fetal developmental protection rights.”

In this process, medical decision-making is no longer a simple drug selection task, but a comprehensive judgment system based on individualized risk assessment, evidence-based medicine, and dynamic clinical monitoring.

With the development of precision medicine and digital healthcare, medication management in pregnancy will gradually shift from experience-driven to data-driven approaches, enabling earlier risk identification, more precise drug selection, and safer maternal–fetal outcomes.

Therefore, the core goal of medication safety in pregnancy can be summarized as:

Ensuring effective control of maternal diseases while maximizing the reduction of fetal exposure risk through scientific medication strategies, ultimately achieving the optimal balance of dual benefit for both mother and fetus.